冠狀病毒檢測套組市場 - 全球產業規模、佔有率、趨勢、競爭格局、機會、預測：按檢測類型、應用、完整檢測時間、技術、檢體類型、移動性、最終用途、地區和競爭格局分類，2021-2031年

全球冠狀病毒檢測套組市場預計將從 2025 年的 172.5 億美元成長到 2031 年的 538.2 億美元，複合年成長率為 20.88%。

這些試劑盒是體外診斷工具，利用分子檢測分析病毒基因和抗原檢測等方法來辨識SARS-CoV-2病毒。全球市場成長的主要驅動力是持續的感染疾病監測需求、正在進行的國際衛生基礎設施建設項目以及各國政府為早期發現和控制疫情而採取的積極措施。此外，SARS-CoV-2株的不斷變異也要求持續研發和部署最先進的診斷設備。

根據世界衛生組織（世衛組織）的數據，2026年3月9日至15日期間，80個國家共進行了64,397次SARS-CoV-2病毒檢測，陽性率為3.3%。隨著疫情初期階段的消退，對大規模檢測的需求下降，這可能是阻礙市場成長的主要障礙。檢測需求的下降將導致價格限制加劇、法律規範發生變化，並最終影響製造商的利潤率及其為診斷基礎設施提供資金的能力。

市場促進因素

病毒的持續傳播和新變種的出現是全球冠狀病毒檢測套組行業的主要驅動力。由於SARS-CoV-2病毒不斷變異，對監測以準確識別和區分活性株以及開發尖端診斷設備的需求始終不減。這種適應性在顯著改變的BA.3.2變種中得到了充分體現，與先前的版本相比，其刺突蛋白中存在約70-75個突變或缺失。正如美國疾病管制與預防中心（CDC）2026年3月發布的關於2024年11月至2026年2月全球早期檢測的報告中所強調的那樣，荷蘭、德國和丹麥的BA.3.2每週檢出率在2025年11月至2026年1月期間有所上升，約佔病毒序列的30%。這表明，需要持續進行檢測以識別新的變種並指導公共衛生策略，從而確保對先進診斷工具的穩定需求。

對就地檢驗和居家檢測產品日益成長的需求也對新冠病毒檢測套組市場產生了顯著影響。這些檢測產品具有快速出結果、操作簡單、覆蓋範圍廣等優點，使人們能夠離開傳統的醫療機構進行自我檢測，從而加快隔離和醫療護理方面的決策。這種轉變賦予了大眾更多掌控自身健康的能力。為了佐證這一趨勢，雅培公司在2026年1月發布的報告顯示，其即時診斷業務在2025會計年度第四季的銷售額成長了7%。這一成長凸顯了消費者向分散式診斷方式的顯著轉變。最終，這些檢測套組的市場將繼續適應不斷變化的消費者需求，雅培公司表示，其2025會計年度第四季的新冠病毒檢測銷售額為8,900萬美元。

市場挑戰

全球新冠病毒檢測套組產業擴張面臨的主要障礙之一是大規模檢測需求的下降。隨著全球疫情逐漸消退，大規模篩檢計畫的需求減少，市場價格競爭日益激烈。消費者需求的下降以及由此導致的價格下跌直接影響了製造商的利潤率，並限制了他們投資研發新型診斷設備以及擴大生產基礎設施的能力和意願。

根據歐洲醫療技術協會（MedTech Europe）發布的數據，2023年歐盟27國、歐洲自由貿易聯盟成員國和英國的體外診斷行業整體銷售額較2022年大幅下降20.2%。這一降幅主要歸因於新冠病毒檢測數量的減少。這一趨勢凸顯了大規模篩檢需求的降低如何對新冠病毒診斷試劑盒生產商的財務穩定性和長期投資計畫產生負面影響。

市場趨勢

全球冠狀病毒檢測套組市場正經歷著多重診斷檢測組合的重大轉變。這種轉變的特點是，只需一份檢體即可同時辨識多種呼吸道病原體，包括SARS-CoV-2、流感病毒和呼吸道融合細胞病毒（RSV）。此類進步有助於克服區分症狀通用的疾病的醫學難題，從而實現更準確的診斷和個人化治療方案。透過應用這些綜合檢測組合，實驗室可以提高效率、簡化檢測流程，並省去進行大量單項檢測的需要。 Cepheid的母公司丹納赫在2025年第四季財報中宣布，新產品營收年增約25%，部分原因是其多重診斷產品線的拓展。

另一個影響產業的顯著趨勢是非侵入檢體採集技術的發展。雖然鼻咽拭子檢測曾經很常見，但其帶來的身體不適促使人們傾向於選擇其他方法。例如，唾液檢測等新型方法對患者更加友好，操作更簡便，且可在常規臨床環境之外輕鬆進行自我採集。隨著便利的診斷工具在疫情爆發期間變得愈發重要，預計這將提高檢測的可及性並提升依從率。例如，《科學家》雜誌在2025年8月報道，美國食品藥物管理局（FDA）已對第五種基於唾液的COVID-19診斷測試發布了緊急使用授權（EUA），這體現了這些非侵入性檢測方法在核准和應用方面取得的進展。

目錄

第1章 產品概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球新冠病毒檢測套組市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依檢測類型（分子檢測與血清學檢測）
  • 按應用方式（多次測試與單次測試）
  • 依時長分類的完整檢查時間（5-12 小時、1-5 小時、15-60 分鐘、少於 15 分鐘、12-24 小時、1 天或以上）
  • 依技術分類（RT-PCR、快速診斷測試、ELISA 測試等）
  • 檢體類型（鼻咽檢體、口咽檢體、血液、痰液、其他）
  • 移動性（固定式、移動式）
  • 依最終用途（公共衛生檢查室、醫院、私人或商業檢查室、醫生檢查室、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美新冠病毒檢測套組市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲新冠病毒檢測套組市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區冠狀病毒檢測套組市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲新冠病毒檢測套組市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲新冠病毒檢測套組市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球新冠病毒檢測套組市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Abbott Laboratories
• Roche Diagnostics
• Thermo Fisher Scientific Inc.
• Quidel Corporation
• Bio-Rad Laboratories, Inc.
• Siemens Healthineers AG
• Becton, Dickinson and Company
• F. Hoffmann-La Roche AG
• Danaher company
• Hologic, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global market for coronavirus testing kits is anticipated to expand from USD 17.25 billion in 2025 to USD 53.82 billion by 2031, reflecting a compound annual growth rate of 20.88%. These kits are in vitro diagnostic tools created to identify the SARS-CoV-2 virus using methods such as molecular testing for viral genetics or antigen evaluations for specific viral proteins. The growth of this global market is mainly fueled by the ongoing need for infectious disease monitoring, continuous international health readiness programs, and forward-thinking government actions aimed at early identification and containment. Additionally, the constant mutation of SARS-CoV-2 strains requires the continuous creation and rollout of modernized diagnostic instruments.

Data from the World Health Organization indicates that between March 9 and March 15, 2026, 64,397 tests for SARS-CoV-2 were conducted in 80 nations, yielding a 3.3% positivity rate. A major obstacle potentially slowing market growth is the waning need for widespread testing as the initial pandemic emergency phases out. This decline results in heightened pricing constraints and shifting regulatory frameworks, ultimately impacting the profit margins of manufacturers and their ability to fund diagnostic infrastructure.

Market Driver

The continuous spread of the virus and the rise of novel variants act as major catalysts for the worldwide coronavirus testing kits industry. As SARS-CoV-2 persistently mutates, there is an uninterrupted need for monitoring and the creation of modernized diagnostic instruments to correctly identify and distinguish active strains. Demonstrating this adaptability is the heavily altered BA.3.2 variant, which features roughly 70 to 75 spike protein mutations and deletions compared to earlier versions. As highlighted in a March 2026 report by the Centers for Disease Control and Prevention regarding global early detection from November 2024 to February 2026, weekly findings of BA.3.2 rose to represent roughly 30% of sequences in the Netherlands, Germany, and Denmark between November 2025 and January 2026. This underscores the enduring requirement for testing to spot fresh variants and guide public health strategies, ensuring steady demand for sophisticated diagnostic tools.

The growing preference for point-of-care and at-home testing products also profoundly impacts the coronavirus testing kit sector. Providing swift outcomes, ease of use, and broad accessibility, these options allow people to test themselves away from conventional medical facilities, thereby accelerating choices regarding isolation and medical care. Such an evolution gives the public more authority over their personal health tracking. Illustrating this movement, Abbott reported in January 2026 that its fourth-quarter point-of-care diagnostic revenues increased by 7% for the 2025 fiscal year. This expansion highlights a clear consumer leaning toward decentralized diagnostics. Ultimately, the market for these kits remains adaptive to shifting consumer needs, with Abbott noting fourth-quarter COVID-19 testing revenues of USD 89 million in 2025.

Market Challenge

A major hurdle impeding the expansion of the global coronavirus testing kits industry is the declining need for widespread population testing. With the immediate emergency phase of the global pandemic fading, the requirement for massive screening programs has dropped, which has consequently triggered severe pricing competition throughout the market. This drop in consumer demand and the resulting price erosion take a direct toll on the profit margins of producers, limiting their capacity and motivation to fund research and development for newer diagnostic instruments or to broaden their manufacturing infrastructure.

Data published by MedTech Europe reveals that the overall in vitro diagnostics sector across the EU27, EFTA, and the United Kingdom saw a massive 20.2% revenue drop in 2023 when compared to 2022, a downturn overwhelmingly caused by falling COVID-19 testing volumes. Such a pattern highlights how the fading urgency for mass screening damages the financial stability and extended investment plans of businesses functioning within the coronavirus diagnostic kit sector.

Market Trends

The worldwide market for coronavirus testing kits is undergoing a notable transition toward multiplexed respiratory panels. This movement features diagnostic evaluations that can concurrently identify several respiratory pathogens, including SARS-CoV-2, influenza, and respiratory syncytial virus, using merely one specimen. Such progress helps overcome the medical difficulty of distinguishing illnesses that share common symptoms, allowing for highly accurate diagnoses and tailored therapy plans. By incorporating these extensive panels, laboratories can boost their productivity, simplify testing workflows, and eliminate the requirement for numerous standalone assays. Illustrating this, Cepheid's parent corporation, Danaher, announced a roughly 25% year-over-year increase in new product earnings during its fourth-quarter 2025 financial report, fueled in part by its deliberate growth in multiplex diagnostic offerings.

An additional prominent trend shaping the industry is the development of sample collection techniques that are less invasive. While nasopharyngeal swabs were previously the norm, the physical discomfort they cause has driven a preference for alternative options. Emerging approaches, such as saliva-based evaluations, provide enhanced comfort for patients, are simpler to administer, and allow for easy self-collection away from standard clinical environments. This expands the availability of testing and can potentially improve compliance as the focus pivots to convenient diagnostic tools during endemic stages. Highlighting the increasing approval and accessibility of these gentler methods, The Scientist noted in August 2025 that the US Food and Drug Administration issued an Emergency Use Authorization for a fifth saliva-based COVID-19 diagnostic test.

Key Market Players

• Abbott Laboratories
• Roche Diagnostics
• Thermo Fisher Scientific Inc.
• Quidel Corporation
• Bio-Rad Laboratories, Inc.
• Siemens Healthineers AG
• Becton, Dickinson and Company
• F. Hoffmann-La Roche AG
• Danaher company
• Hologic, Inc.

Report Scope

In this report, the Global Coronavirus Testing Kits Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Coronavirus Testing Kits Market, By Type of Test

• Molecular
• Serological

Coronavirus Testing Kits Market, By Use

• Multiple Test
• Single Test

Coronavirus Testing Kits Market, By Full Test Time

• 5 Hours- 12 Hours
• 1 Hour- 5 Hours
• 15-60 minutes
• Less than 15 minutes
• 12 Hours - 24 Hours
• More than 1 day

Coronavirus Testing Kits Market, By Technology

• RT-PCR
• Rapid Diagnostic Test
• ELISA Test
• Others

Coronavirus Testing Kits Market, By Specimen

• Nasopharyngeal Specimen
• Oropharyngeal Specimen
• Blood
• Sputum
• Others

Coronavirus Testing Kits Market, By Mobility

• Stationary
• Mobile

Coronavirus Testing Kits Market, By End Use

• Public Health Labs
• Hospitals
• Private or Commercial Labs
• Physician Labs
• Others

Coronavirus Testing Kits Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Coronavirus Testing Kits Market.

Available Customizations:

Global Coronavirus Testing Kits Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Coronavirus Testing Kits Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type of Test (Molecular v/s Serological)
  • 5.2.2. By Use (Multiple Test vs Single Test)
  • 5.2.3. By Full Test Time (5 Hours- 12 Hours, 1 Hour- 5 Hours, 15-60 minutes, Less than 15 minutes, 12 Hours - 24 Hours, More than 1 day)
  • 5.2.4. By Technology (RT-PCR, Rapid Diagnostic Test, ELISA Test, Others)
  • 5.2.5. By Specimen (Nasopharyngeal Specimen, Oropharyngeal Specimen, Blood, Sputum, Others)
  • 5.2.6. By Mobility (Stationary, Mobile)
  • 5.2.7. By End Use (Public Health Labs, Hospitals, Private or Commercial Labs, Physician Labs, Others)
  • 5.2.8. By Region
  • 5.2.9. By Company (2025)
• 5.3. Market Map

6. North America Coronavirus Testing Kits Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type of Test
  • 6.2.2. By Use
  • 6.2.3. By Full Test Time
  • 6.2.4. By Technology
  • 6.2.5. By Specimen
  • 6.2.6. By Mobility
  • 6.2.7. By End Use
  • 6.2.8. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Coronavirus Testing Kits Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type of Test
      • 6.3.1.2.2. By Use
      • 6.3.1.2.3. By Full Test Time
      • 6.3.1.2.4. By Technology
      • 6.3.1.2.5. By Specimen
      • 6.3.1.2.6. By Mobility
      • 6.3.1.2.7. By End Use
  • 6.3.2. Canada Coronavirus Testing Kits Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type of Test
      • 6.3.2.2.2. By Use
      • 6.3.2.2.3. By Full Test Time
      • 6.3.2.2.4. By Technology
      • 6.3.2.2.5. By Specimen
      • 6.3.2.2.6. By Mobility
      • 6.3.2.2.7. By End Use
  • 6.3.3. Mexico Coronavirus Testing Kits Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type of Test
      • 6.3.3.2.2. By Use
      • 6.3.3.2.3. By Full Test Time
      • 6.3.3.2.4. By Technology
      • 6.3.3.2.5. By Specimen
      • 6.3.3.2.6. By Mobility
      • 6.3.3.2.7. By End Use

7. Europe Coronavirus Testing Kits Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type of Test
  • 7.2.2. By Use
  • 7.2.3. By Full Test Time
  • 7.2.4. By Technology
  • 7.2.5. By Specimen
  • 7.2.6. By Mobility
  • 7.2.7. By End Use
  • 7.2.8. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Coronavirus Testing Kits Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type of Test
      • 7.3.1.2.2. By Use
      • 7.3.1.2.3. By Full Test Time
      • 7.3.1.2.4. By Technology
      • 7.3.1.2.5. By Specimen
      • 7.3.1.2.6. By Mobility
      • 7.3.1.2.7. By End Use
  • 7.3.2. France Coronavirus Testing Kits Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type of Test
      • 7.3.2.2.2. By Use
      • 7.3.2.2.3. By Full Test Time
      • 7.3.2.2.4. By Technology
      • 7.3.2.2.5. By Specimen
      • 7.3.2.2.6. By Mobility
      • 7.3.2.2.7. By End Use
  • 7.3.3. United Kingdom Coronavirus Testing Kits Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type of Test
      • 7.3.3.2.2. By Use
      • 7.3.3.2.3. By Full Test Time
      • 7.3.3.2.4. By Technology
      • 7.3.3.2.5. By Specimen
      • 7.3.3.2.6. By Mobility
      • 7.3.3.2.7. By End Use
  • 7.3.4. Italy Coronavirus Testing Kits Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type of Test
      • 7.3.4.2.2. By Use
      • 7.3.4.2.3. By Full Test Time
      • 7.3.4.2.4. By Technology
      • 7.3.4.2.5. By Specimen
      • 7.3.4.2.6. By Mobility
      • 7.3.4.2.7. By End Use
  • 7.3.5. Spain Coronavirus Testing Kits Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type of Test
      • 7.3.5.2.2. By Use
      • 7.3.5.2.3. By Full Test Time
      • 7.3.5.2.4. By Technology
      • 7.3.5.2.5. By Specimen
      • 7.3.5.2.6. By Mobility
      • 7.3.5.2.7. By End Use

8. Asia Pacific Coronavirus Testing Kits Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type of Test
  • 8.2.2. By Use
  • 8.2.3. By Full Test Time
  • 8.2.4. By Technology
  • 8.2.5. By Specimen
  • 8.2.6. By Mobility
  • 8.2.7. By End Use
  • 8.2.8. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Coronavirus Testing Kits Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type of Test
      • 8.3.1.2.2. By Use
      • 8.3.1.2.3. By Full Test Time
      • 8.3.1.2.4. By Technology
      • 8.3.1.2.5. By Specimen
      • 8.3.1.2.6. By Mobility
      • 8.3.1.2.7. By End Use
  • 8.3.2. India Coronavirus Testing Kits Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type of Test
      • 8.3.2.2.2. By Use
      • 8.3.2.2.3. By Full Test Time
      • 8.3.2.2.4. By Technology
      • 8.3.2.2.5. By Specimen
      • 8.3.2.2.6. By Mobility
      • 8.3.2.2.7. By End Use
  • 8.3.3. Japan Coronavirus Testing Kits Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type of Test
      • 8.3.3.2.2. By Use
      • 8.3.3.2.3. By Full Test Time
      • 8.3.3.2.4. By Technology
      • 8.3.3.2.5. By Specimen
      • 8.3.3.2.6. By Mobility
      • 8.3.3.2.7. By End Use
  • 8.3.4. South Korea Coronavirus Testing Kits Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type of Test
      • 8.3.4.2.2. By Use
      • 8.3.4.2.3. By Full Test Time
      • 8.3.4.2.4. By Technology
      • 8.3.4.2.5. By Specimen
      • 8.3.4.2.6. By Mobility
      • 8.3.4.2.7. By End Use
  • 8.3.5. Australia Coronavirus Testing Kits Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type of Test
      • 8.3.5.2.2. By Use
      • 8.3.5.2.3. By Full Test Time
      • 8.3.5.2.4. By Technology
      • 8.3.5.2.5. By Specimen
      • 8.3.5.2.6. By Mobility
      • 8.3.5.2.7. By End Use

9. Middle East & Africa Coronavirus Testing Kits Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type of Test
  • 9.2.2. By Use
  • 9.2.3. By Full Test Time
  • 9.2.4. By Technology
  • 9.2.5. By Specimen
  • 9.2.6. By Mobility
  • 9.2.7. By End Use
  • 9.2.8. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Coronavirus Testing Kits Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type of Test
      • 9.3.1.2.2. By Use
      • 9.3.1.2.3. By Full Test Time
      • 9.3.1.2.4. By Technology
      • 9.3.1.2.5. By Specimen
      • 9.3.1.2.6. By Mobility
      • 9.3.1.2.7. By End Use
  • 9.3.2. UAE Coronavirus Testing Kits Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type of Test
      • 9.3.2.2.2. By Use
      • 9.3.2.2.3. By Full Test Time
      • 9.3.2.2.4. By Technology
      • 9.3.2.2.5. By Specimen
      • 9.3.2.2.6. By Mobility
      • 9.3.2.2.7. By End Use
  • 9.3.3. South Africa Coronavirus Testing Kits Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type of Test
      • 9.3.3.2.2. By Use
      • 9.3.3.2.3. By Full Test Time
      • 9.3.3.2.4. By Technology
      • 9.3.3.2.5. By Specimen
      • 9.3.3.2.6. By Mobility
      • 9.3.3.2.7. By End Use

10. South America Coronavirus Testing Kits Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type of Test
  • 10.2.2. By Use
  • 10.2.3. By Full Test Time
  • 10.2.4. By Technology
  • 10.2.5. By Specimen
  • 10.2.6. By Mobility
  • 10.2.7. By End Use
  • 10.2.8. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Coronavirus Testing Kits Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type of Test
      • 10.3.1.2.2. By Use
      • 10.3.1.2.3. By Full Test Time
      • 10.3.1.2.4. By Technology
      • 10.3.1.2.5. By Specimen
      • 10.3.1.2.6. By Mobility
      • 10.3.1.2.7. By End Use
  • 10.3.2. Colombia Coronavirus Testing Kits Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type of Test
      • 10.3.2.2.2. By Use
      • 10.3.2.2.3. By Full Test Time
      • 10.3.2.2.4. By Technology
      • 10.3.2.2.5. By Specimen
      • 10.3.2.2.6. By Mobility
      • 10.3.2.2.7. By End Use
  • 10.3.3. Argentina Coronavirus Testing Kits Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type of Test
      • 10.3.3.2.2. By Use
      • 10.3.3.2.3. By Full Test Time
      • 10.3.3.2.4. By Technology
      • 10.3.3.2.5. By Specimen
      • 10.3.3.2.6. By Mobility
      • 10.3.3.2.7. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Coronavirus Testing Kits Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbott Laboratories
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Roche Diagnostics
• 15.3. Thermo Fisher Scientific Inc.
• 15.4. Quidel Corporation
• 15.5. Bio-Rad Laboratories, Inc.
• 15.6. Siemens Healthineers AG
• 15.7. Becton, Dickinson and Company
• 15.8. F. Hoffmann-La Roche AG
• 15.9. Danaher company
• 15.10. Hologic, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer